SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. ($BNAI) is experiencing a parabolic surge, fueled by its recent Valio Technologies deal and AI initiatives, alongside an extremely low share float and high short interest leading to soaring borrow rates. The trading community is intensely focused on a massive short squeeze, drawing parallels to previous extreme volatility events and speculating on triple-digit price targets. This intense interest has positioned $BNAI as a highly speculative play within the broader AI microcap sector.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is trending due to significant government and private investment aimed at bolstering domestic rare earth production. The community is actively debating the impact of the multi-billion dollar funding on the company's valuation, with many anticipating a substantial surge and a short squeeze. This move is broadly seen as a strategic play to secure critical minerals and reduce reliance on foreign supply chains.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust ($SLV) is experiencing a parabolic surge, shattering past price levels and fueling intense bullish sentiment across the community. Many are calling it unstoppable, driven by concerns over currency devaluation and robust industrial demand, while bears anticipate a significant profit-taking pullback or rotation to other commodities. The ongoing discussion highlights a major short squeeze and a re-evaluation of silver's intrinsic value amidst broader market shifts.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending due to its Breakthrough Therapy Designation for pemvidutide in MASH, which has amplified discussions around its best-in-class potential in the rapidly growing MASH and obesity markets. The community is largely bullish, anticipating a significant strategic partnership or acquisition given the drug's dual-action benefits and favorable safety profile. However, some market participants remain cautious, citing concerns about past trial data and potential market manipulation influencing recent price action.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending as gold prices reach unprecedented levels, with community discussion centered on its role as a premier safe haven asset amid heightened global geopolitical tensions and concerns over currency stability. Many investors are celebrating significant gains and anticipating further upside, while some caution about an overextended market and the potential for a sharp correction. This rally is widely perceived as a flight to quality, driven by central bank diversification and a diminishing trust in traditional financial assets.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending sharply after reporting promising interim Phase 1 data for its obesity candidate, WVE-007, which demonstrated visceral fat reduction and muscle preservation, a key differentiator from current GLP-1 therapies. The financial community is actively debating its potential to revolutionize obesity treatment with less frequent dosing and an improved side effect profile, fueling intense speculation about the company's appeal as an acquisition target for major pharmaceutical firms.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab (RKLB) is trending following a successful Electron launch and a flurry of analyst upgrades, alongside anticipation for upcoming missions and major defense contracts in the expanding space sector. However, discussions are also heating up around a Neutron rocket tank rupture during testing; while many see this as a necessary development step, others are concerned about potential delays impacting the larger rocket's timeline. This blend of operational success and development challenges is fueling a dynamic conversation among investors.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is drawing significant attention ahead of its anticipated earnings report, with community discussion sharply divided between long-term bullish sentiment fueled by institutional accumulation and the potential for S&P 500 inclusion, and intense frustration over persistent price stagnation and perceived market manipulation. Many investors are buying recent dips, anticipating a breakout, despite ongoing concerns about dilution and broader fintech sector pressures.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is a major talking point in the biotech sector, driven by recent clinical data showcasing an an 81% disease control rate in advanced pancreatic cancer using its Alpha DaRT technology. The community is highly anticipating an imminent PMDA approval in Japan and is closely watching for further developments from its FDA submissions, with increasing institutional interest noted.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending following its U.S. subsidiary's submission of a consolidated deep-seabed mining application to NOAA, a move that significantly expands its potential recovery area and streamlines the permitting process. This development, coupled with broader U.S. government focus on securing critical mineral supply chains, has ignited extremely bullish sentiment within the community. Investors are actively discussing the likelihood of swift permit approval and anticipating substantial upside driven by national security implications and the urgency to reduce reliance on foreign mineral sources.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Provident Financial Holdings, Inc. (NASDAQ:PROV) Announces Quarterly Dividend of $0.14

Provident Financial Holdings, Inc. (NASDAQ:PROV) announced a quarterly dividend on Thursday, January 22nd. Stockholders of record on Thursday, February 12th will be given a dividend of 0.14 per share...

Provident Financial (PROV) Expected to Announce Earnings on Tuesday

Provident Financial (NASDAQ:PROV) will be releasing its Q2 2026 earnings before the market opens on Tuesday, January 27. (View Earnings Report at...

Provident Financial (NASDAQ:PROV) Upgraded at Zacks Research

Zacks Research raised shares of Provident Financial from a "strong sell" rating to a "hold" rating in a research note on Monday...

Provident Financial (NASDAQ:PROV) Stock Passes Above 200-Day Moving Average - Here's What Happened

Provident Financial (NASDAQ:PROV) Stock Crosses Above 200-Day Moving Average - Here's What Happened...

Provident Financial (NASDAQ:PROV) SVP Sells 4,800 Shares

Provident Financial Holdings, Inc. (NASDAQ:PROV - Get Free Report) SVP Gwendolyn Wertz sold 4,800 shares of Provident Financial stock in a transaction dated Wednesday, November 12th. The shares were...

Insider Selling: Provident Financial (NASDAQ:PROV) SVP Sells 4,800 Shares of Stock

Provident Financial Holdings, Inc. (NASDAQ:PROV - Get Free Report) SVP Gwendolyn Wertz sold 4,800 shares of the stock in a transaction on Wednesday, November 12th. The shares were sold at an average...

Provident Financial (PROV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Provident Financial (PROV) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Provident Financial (PROV) Misses Q1 Earnings and Revenue Estimates

Provident Financial (PROV) delivered earnings and revenue surprises of -13.79% and -5.41%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Provident Financial (PROV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Provident Financial (PROV) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Provident Financial (PROV) Misses Q4 Earnings and Revenue Estimates

Provident Financial (PROV) delivered earnings and revenue surprises of -17.24% and -6.14%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Provident Financial Holdings, Inc. engages in the provision of financial services. Its services include checking, savings, investment services, mobile banking, online banking, merchant services, cyber security tips, loan programs, and applications. The company was founded in January 1996 and is headquartered in Riverside, CA.

Provident Financial Holdings, Inc.

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

Current Price	$16.30
Prev Close	$16.27
Open	$16.27
Dividend Yield	3.61%
50-Day Moving Average	$15.73
Beta	0.24
Avg. Volume	9,666.55
PE Ratio	18.06

52-Week High	$16.36
52-Week Low	$12.98
Market Capitalization	$280.56M
EPS (Annual)	$0.9252
Price to Book	0.83
Revenue Per Employee	$369,049.08
Enterprise Value/EBITDA	N/A

PROV
Provident Financial Holdings, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PROV News

PROVProvident Financial Holdings, Inc.